All news

Regeneron Pharmaceuticals (NASDAQ:REGN) Director Sells 400 Shares of Company Stock

Alpha Vantage · MarketBeat · · AI-summarised by FinFlash

Regeneron Pharmaceuticals Director Kathryn Guarini sold 400 shares of company stock on October 30th for $360,000, reducing her direct ownership to 603 shares. The sale occurred under a pre-arranged Rule 10b5-1 trading plan. The company recently reported strong Q3 earnings, beating analyst expectations with $20.07 EPS and $5.12 billion in revenue, and announced a quarterly dividend of $0.94 per share.

Read original source

REGN company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.